Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Baltimore Buprenorphine Initiative: A Case Study of System Change Robert P. Schwartz, M.D. Friends Research Institute Open Society Institute-Baltimore Stakeholders & Leaders Baltimore City Health Department (BCHD) Joshua Sharfstein, M.D.; Marla Oros, R.N; Vanessa Kuhn Baltimore Substance Abuse Systems (BSAS) Adam Brickner; Bonnie Cypull, M.S.W. Baltimore Health Care Access (BHCA) Kathleen Westcoat; Tracey Kodek, Sadie Matarazzo Mid-Atlantic Community Health Center Association Rebecca Ruggles Treatment Providers Tracy Schulden, Wendy Merrick Maryland Medical Society Meena Abraham, M.P.H. Foundations Abell, Annie E. Casey, Bearman, Kreiger, Open Society Institute-Baltimore, & Weinberg Heroin Addiction: The Problem • Baltimore has a storied history of heroin addiction • Most addicted individuals are not in treatment • Treatment capacity is inadequate to meet demands Buprenorphine • Partial opioid agonist • Effective in reducing heroin use • Longer treatments at higher doses yield better outcomes • Good safety profile • Available by prescription since Fall 2002 • Certain restrictions apply • MD offices, community health clinics, drug-free outpatient treatment, hospital and STD clinics, needle exchange programs Infuse the Health System • Community Health Centers: 2002 – 2005 • Started 90-day detoxes at 4 centers • Resistance to longer-term treatment met by compromise • Medical Society: 2003 -2004 • Increase interest in obtaining the “waiver “ • Educational sessions • Surveyed members about barriers • Hospital Outpatient Clinics: 2005 -2006 • Expanded treatment into 4 clinics Formulary Approval • Buprenorphine was included in Maryland Department of Health’s drug formulary (2003) through the effort of CSAT, the State Health Department, Medicaid Program and Alcohol and Drug Abuse Administration • Medicaid Program • Primary Adult Care Program • Ryan White Program Change the Treatment System Baltimore Substance Abuse Systems (BSAS) • 6 providers were offering 3- 10 day buprenorphine detox • June 2005: Community Health Centers presented outcome data for their 90-day buprenorphine programs • BSAS proposed change to a longer-term model • August 2005: BSAS convened a provider roundtable • Some resistant to change • Thought their outcomes were good Data Drives the Plan November 2005: New Health Commissioner BSAS presents short-term detox outcome data: • Completion rate: 66% • 90-day retention: 18% BSAS mandates future migration to longer-term treatment • Continue provider roundtable • Begin MD meetings • Seeks to maximize use of public insurance coverage Goal • Reduce the city’s heroin-addiction problem • Transform its buprenorphine treatment model from shortterm detoxification to longer-term treatment • • Expand access to effective treatment • build on the existing medical system • utilize existing public health insurance Improve patient outcomes Leadership for Change Health Department BHCA Physician Roundatable BSAS Provider Roundatable Coordinating Committee: Change-Structure • Key lead agencies: BCHD, BHCA and BSAS • Each agency had clear role • BCHD: recruit physicians, paid for waiver training • BHCA: case management, benefits coordination, advocated with state and MCOs, drafted procedures • BSAS: treatment, practice guidelines, shifted funding • Each agency dealt with its strength • Dealt with new issues as they arose • Buprenorphine urine test, ID cards for benefits, drug testing for health center, bulk purchasing Provider Roundtable: Preparing to Change • Program directors and BCHD, BSAS and BHCA • Decision-making by consensus • Minutes distributed • BHCA wrote protocols and forms for the providers • All documents considered drafts • Alleviated strain on providers and delay Protocols • Counseling and Medication • Pharmacy relationships - Billing • BHCA prepared patients for transfer • Patient “passport” - MD to MD: Transfer criteria, drug testing, med/psych history, dose, recommended frequency of visits Switch to Longer-term Treatment: July 2006 • Contract SNAFU needs fixing • September 2006: Provider pushback - BSAS doesn’t want to dictate to providers - Some providers resist longer-term therapy - Resist cross-site standardization, case managers, paper work - Resolved through leadership & consensus building • BCHD & BHCA met with primary care providers Outcomes • 1,367 patients treated • 33%: currently enrolled in treatment • 25%: transferred to primary care • Average of 163 days in drug program prior to transfer • 57% retained in treatment at least 90 days • Includes patients who wanted shorter-term treatment • MTP retention (83%) short-term detox retention (18%) • 83 % obtained health benefits • 82 new MD “waivers” Principles of Implementation Keep Your Eye on the Big Picture • City’s mission: treatment-on-demand • Focus on the patient Chose Intervention Wisely • Scan national environment for evidence-based treatments • NIDA Clinical Trials Network, local University researchers, ATTCs • Can it impact a major problem? • Can it be implemented in stages, if necessary? • Can it be implemented with fidelity? • Can it be brought to scale? Effective Leaders Dedicated staff with allocated time Good interpersonal skills - collaborative Organized Respected lines of authority Provided technical assistance during change to all players Good Communication: Internal • Provider and MD Roundtables • Regularly scheduled, rotated site w/food • Respectful and incorporated feedback to build trust • Flexible but persistent • It became a priority for the providers • BHCA prepared documents and organized meeting • MDs began to play a more active role in these formerly “drugfree” treatment programs Good Communication: External • Get support from community leaders & key stakeholders - Mayor, Health Commissioner & Congressman wrote letters to hospital CEOs to get their plan to train MDs - Garnered support from legislators and judges • Email list-serve updates • Release summary reports • Press conference • Prepare for challenges at every step Use External Experts Expert Advisory Group Expert MDs to consult with practitioners • Dosing • Counseling • Prescribing practices Diversify Funding • Federal, state and local grants • Health insurance: Medicaid and state programs • Local and national foundations • Redirect existing drug treatment money • Special populations • HIV • Criminal justice • Social Services Use Meaningful Incentives Health Centers: free drug testing, patients with benefits, case management Drug Treatment Providers: increased funding, case management, discounted medications through bulk purchasing Physicians: BCHD paid for waiver and training Patients: better treatment, case management, health benefits Lesson Learned One project can teach you about the strengths and weaknesses of the entire system